Medios AG
MED.DESDAX
4,12 €
Dividend yield0,97 %
Continuity3 yr
Dividend0,04 €
DiviScore
RiskPerformance25/35
Dividend Quality4/35
AGM Date
28.05.2026Ex-Date
29.05.2026Payment
02.06.2026CAGR 3Y
+9.9%CAGR 5Y
-0.1%CAGR 10Y
-2.6%€10,000 invested in 2016 · with dividend reinvestment
End Value
25.744,62 €
Total Return
+157.4%
Annual Return
9.9% p.a.
Dividends Received
15.467,95 €
Dividend history
About Medios AG
Medios, based in Berlin, is a specialist pharmaceutical company focused on patient-specific medicines, preparing tailored treatments for cancer and chronic conditions and supplying speciality drugs to pharmacies. It sits in a growing niche where personalised medicine and complex therapies are becoming more common. Medios pays only a small dividend, reinvesting to expand its specialty-pharma platform through growth and acquisitions, so the yield is minimal. This is a healthcare growth stock valued for its position in personalised medicine rather than for income.
Frequently Asked Questions
The next payment date is 02.06.2026.
Medios AG has a DiviScore of 42/100. DiviScore rates dividend stocks based on price performance, dividend quality, fundamentals, and stability.
Medios AG's current dividend yield is 0.97% based on the latest dividend.
Medios AG (MED.DE) is a member of SDAX. Current data including price, dividend, and DiviScore is updated daily.
DiviScore is a proprietary 100-point rating based on four pillars: Performance (35 pts), Dividend Quality (35 pts), Fundamentals (15 pts), and Stability (15 pts). It simulates a 10-year investment with automatic dividend reinvestment.